Catalyst Wire Dossier Catalyst Wire Dossier

OraQuick ADVANCE HIV-1/2 Rapid Antibody Test

· OraSure Technologies, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OraQuick ADVANCE HIV-1/2 Rapid Antibody Test, covering 2024-07-30 to 2024-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood [NA]

See pricing